Bigul

Aarti Pharmalabs Ltd - 543748 - Certificate Pursuant To Regulation 40(9) Of The SEBI (LODR) Regulations, 2015

Certificate pursuant to Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024.
12-04-2024

Aarti Pharmalabs Ltd - 543748 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
04-04-2024

Aarti Pharmalabs Ltd - 543748 - Compliance Certificate For The Financial Year Ended March 31, 2024

Compliance Certificate pursuant to Regulation 7(3) of SEBI LODR Regulations.
04-04-2024

Aarti Pharmalabs Ltd - 543748 - Closure of Trading Window

Intimation of closure of trading window
27-03-2024

AARTIPHARM Consolidated December 2023 Net Sales at Rs 448.69 crore, down 69.27% Y-o-Y

20-02-2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Q3 FY24 Earnings conference call
13-02-2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication of Audited Financial Results for the quarter and nine months ended December 31, 2023
09-02-2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Recording of Earnings Conference Call for Q3 / 9M FY24
08-02-2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation

Q3 FY24 Investor Presentation
08-02-2024

Aarti Pharmalabs Ltd - 543748 - Corporate Action-Board approves Dividend

Interim Dividend for FY 2023-24
07-02-2024